| Name | Title | Contact Details |
|---|
Water Lens is an innovative company that is revolutionizing the $10B water testing industry. We have developed a system for real-time chemical analysis of water and other fluids, on location, for industries that use large amounts of water (e.g., oil and gas, agriculture, power generation, coal mining, and food processing).
Hillcrest Educational Foundation is a private not-for-profit agency that provides a range of individualized and comprehensive clinical, psychological and special education services for children, adolescents and families in Berkshire County, MA and the Northeast. The students served by Hillcrest in nonresidential and residential programs have complex psychiatric, behavioral and/or developmental disorders, including Autism Spectrum Disorders, and a variety of high-risk behaviors. The programs and services provided by the Hillcrest Educational Foundation are state licensed and certified, and Hillcrest Educational Centers, including Hillcrest Community Support Services, is accredited in behavioral health care by the Joint Commission.
Alliance for Health Care Reform is a Washington, DC-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bid Prep is a Aliso Viejo, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
BioSig Technologies, Inc. (OTCQB: BSGM) is a medical device company that is developing a proprietary technology platform to address an unmet technology need in the rapidly growing $4.6+ billion electrophysiology (EP) marketplace. Led by a proven management team, world-class Board of Directors and Scientific Advisory Board, Minneapolis-based BioSig Technologies is preparing to commercialize its PURE EP™ System. The PURE EP System is a surface electrocardiogram (ECG) and intracardiac multichannel recording and analysis system designed to assist electrophysiologists in making crucial clinical decisions in real-time by acquiring and displaying high-fidelity cardiac signal recordings even at undetectable levels (until now) with high accuracy to help identify appropriate catheter ablation targets - areas of tissue to destroy that create a heart rhythm disturbance (arrhythmia). BioSig`s main goal is to deliver technology to improve upon catheter ablation treatments for the prevalent and deadly arrhythmias, Atrial Fibrillation and Ventricular Tachycardia. PURE EP is an innovative platform, offering potential benefits over current technologies including increased accuracy, reduced noise and interference, clinical information previously not available and potential elimination of the need for repeat procedures. BioSig has partnered with Minnetronix on technology development and is working toward FDA 510(k) clearance for the PURE EP System.